WuXi Biologics (Cayman) Inc. Website

WuXi Biologics (Cayman) Inc.

SEHK-2269

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

3,983.7

5,612.4

10,290.1

15,268.7

17,034.3

17,116.4

Total Revenues % Chg.

—

57.2%

40.9%

83.3%

48.4%

11.6%

3.4%

Cost of Goods Sold, Total

2,325

3,079.4

5,461.2

8,544.6

10,206.4

10,499.2

Gross Profit

1,658.7

2,533

4,828.9

6,724

6,827.9

6,617.2

Selling General & Admin Expenses, Total

444.4

605.9

1,000.6

1,432.5

1,789.4

2,000.4

Provision for Bad Debts

—

—

—

6.7

116.1

132.4

260

296.5

356

R&D Expenses

259.7

303.7

501.6

682.8

785.8

788.4

Other Operating Expenses

—

—

—

—

—

—

5

24.3

-1.5

23.5

22.3

Other Operating Expenses, Total

710.7

1,030.6

1,658.8

2,373.8

2,895.2

3,167.2

Operating Income

948

1,502.3

3,170.1

4,350.2

3,932.7

3,450.1

Interest Expense, Total

—

-19.6

-42.7

-39.2

-64.4

-158.5

-147.7

Interest And Investment Income

75.8

80.9

58

115.8

219.2

336.3

Net Interest Expenses

56.1

38.1

18.8

51.4

60.7

188.6

Income (Loss) On Equity Invest.

—

—

—

—

—

-3.1

2.6

—

—

—

—

Currency Exchange Gains (Loss)

8.1

-91.3

-32.6

417.2

46.7

-211.4

Other Non Operating Income (Expenses)

114

142.5

171.4

159.6

173.4

199.7

EBT, Excl. Unusual Items

1,123.1

1,594.3

3,327.7

4,978.3

4,213.5

3,627

Gain (Loss) On Sale Of Investments

—

—

—

3.5

371.4

665.4

379.4

13.8

72.4

Other Unusual Items

—

—

—

—

—

—

—

—

—

-53.6

-46.2

EBT, Incl. Unusual Items

1,126.6

1,965.8

3,993.1

5,357.8

4,173.8

3,653.2

Income Tax Expense

116.3

273.1

484.5

807.9

603.2

640.1

Earnings From Continuing Operations

1,010.3

1,692.7

3,508.6

4,549.9

3,570.6

3,013.1

Minority Interest

—

—

—

—

3.5

-3.8

-120.1

-129.6

-170.9

-380.9

Net Income

1,013.8

1,688.9

3,388.5

4,420.3

3,399.7

2,632.1

Net Income to Common Incl Extra Items

1,013.8

1,688.9

3,388.5

4,420.3

3,399.7

2,632.1

Net Income to Common Excl. Extra Items

1,013.8

1,688.9

3,388.5

4,420.3

3,399.7

2,632.1

Total Shares Outstanding

3,883.6

4,084.8

4,224.4

4,225.3

4,222.7

4,151.4

Weighted Avg. Shares Outstanding

3,717.1

3,953

4,173.7

4,172.7

4,163.5

4,135.9

Weighted Avg. Shares Outstanding Dil

3,997.1

4,209.2

4,421.8

4,375.9

4,348.9

4,301.9

EPS

0.3

0.4

0.8

1.1

0.8

0.6

EPS Diluted

0.3

0.4

0.8

1

0.8

0.6

EBITDA

1,141.3

1,771.2

3,622.3

5,068.8

4,928.2

4,583.9

Effective Tax Rate

10.3%

13.9%

12.1%

15.1%

14.5%

17.5%